4 June, 2026
In a historic mobilization of the European health sector, the European Respiratory Society (ERS), alongside a coalition of nearly 500 organizations, research institutions, and patient advocacy groups, has launched an urgent appeal to the highest echelons of European governance. As negotiations for the European Union’s next Multiannual Financial Framework (MFF) reach a critical juncture, the message from the health community is clear: Europe’s economic competitiveness is inextricably linked to the vitality of its citizens.
The coalition is demanding that health be formalized as a core strategic priority, underpinned by a dedicated, ringfenced budget. This unprecedented joint action serves as a stark warning to European Commission President Ursula von der Leyen, European Council President António Costa, and the governments of EU Member States: a strategy that prioritizes industrial competitiveness while neglecting public health is fundamentally flawed and economically unsustainable.
The Core Mandate: Why Health is the New Economic Imperative
At the heart of this advocacy campaign lies a simple but profound premise: you cannot build a resilient, competitive economy on the back of an unhealthy population. For decades, health policy has often been treated as a secondary concern, managed primarily at the national level. However, the post-pandemic era, combined with the rising burden of non-communicable diseases (NCDs) and an aging demographic, has forced a re-evaluation of this siloed approach.
The joint letter argues that the EU’s current trajectory—placing economic security and technological sovereignty at the center of its future strategy—is missing a vital pillar. By failing to integrate health into the core financial structure of the next MFF, the Union risks undermining its own industrial goals. The coalition asserts that investment in health is not merely a social expenditure; it is a prerequisite for a stable, productive workforce and a sustainable social welfare system.
Chronology of a Campaign: From Policy Proposals to Collective Action
The current push for a ringfenced health budget did not materialize in a vacuum; it is the culmination of years of lobbying and strategic alignment within the European health sector.
- Early 2025: Initial discussions begin within the European health policy community regarding the upcoming MFF negotiations. Stakeholders identify the need to move beyond the reactive health funding models used during the COVID-19 pandemic.
- Late 2025: Preparatory advocacy begins, with organizations like the ERS engaging with MEPs to emphasize the economic impact of chronic respiratory and non-communicable diseases.
- Spring 2026: The European Parliament makes a decisive move, adopting a formal position on the next MFF that strongly advocates for a dedicated health budget. Crucially, the Parliament proposes an investment of €10 billion specifically for health-related initiatives.
- May 2026: The ERS and its partners finalize the joint letter, consolidating the voices of researchers, academics, civil society, and patient advocates into a single, unified demand.
- 4 June, 2026: The letter is officially presented to the European Commission and the European Council, marking the launch of a high-stakes advocacy phase directed at national governments.
The focus now shifts to the European Council, where the individual positions of Member States will dictate the final outcome of the MFF negotiations. While some nations have signaled an openness to increased health investment, others remain wary of expanding the EU’s budgetary commitments, setting the stage for a tense negotiation period in the coming months.
Supporting Data: The High Cost of Inaction
To justify the demand for a ringfenced budget, the coalition relies on compelling data provided by organizations such as the World Health Organization (WHO). The figures serve as a sobering reminder of the financial toll of preventable disease.
The Productivity Gap
Current WHO estimates indicate that Europe loses approximately €442 billion in annual productivity due to avoidable deaths linked to non-communicable diseases. This staggering figure represents not just a failure of public health policy, but a massive drain on the European economy. When individuals are incapacitated or pass away prematurely due to manageable health conditions, the Union loses talent, expertise, and tax revenue.
The Return on Investment (ROI)
The health community argues that the €10 billion proposed by the European Parliament is a modest insurance policy against future volatility. Investing in early diagnosis, preventative screenings, and advanced research for chronic conditions such as respiratory illnesses, cancer, and heart disease offers a high return on investment. By curbing the prevalence of NCDs, the EU can significantly reduce the long-term strain on national healthcare systems and enhance the overall labor participation rate.
Official Responses and the Advocacy Stance
The advocacy effort is led by some of the most respected voices in the medical and scientific community. Prof. Barbara Hoffmann, ERS Advocacy Council Chair, has been a leading voice in articulating the moral and economic necessity of the budget request.
The Moral Imperative
In her statement, Prof. Hoffmann underscored that health transcends politics: "Health is not a luxury—it is a human right." This sentiment is central to the coalition’s argument, challenging the notion that health spending should be subject to the same cyclical austerity measures as other, less essential sectors.
The Economic Reality
Addressing the fiscal concerns of EU leaders, Prof. Hoffmann warned against short-termism: "Spending for health and prevention may seem significant now, but the cost of inaction will be much higher in the future. I urge EU leaders and Member States to take this opportunity to play their part in protecting the future health of European citizens."
The coalition’s argument is strategic: by locking in a ringfenced budget, the EU can ensure that health infrastructure remains resilient regardless of political shifts or changes in leadership. It moves health from a "discretionary" line item to a "structural" necessity.
Implications: What is at Stake for the European Union?
The outcome of these negotiations will have profound, long-term implications for the future of the European project.
1. Strengthening the "European Health Union"
A dedicated budget would signify the maturation of the European Health Union. It would provide the European Commission with the tools to coordinate cross-border health threats, harmonize standards for patient care, and foster a truly integrated European research ecosystem. Without a dedicated budget, the "Health Union" remains largely a concept—an aspirational framework without the financial teeth to enforce change.
2. Resilience Against Future Pandemics
The COVID-19 pandemic exposed the fragility of European supply chains for medical equipment and pharmaceuticals. A ringfenced budget would allow for the development of strategic stockpiles, the support of localized manufacturing for essential medicines, and the creation of rapid-response mechanisms that do not rely on ad-hoc emergency funding.
3. Competitiveness and the Aging Workforce
As Europe faces a demographic cliff, the health of the existing workforce becomes the most critical asset for economic stability. A society that is chronically ill is a society that cannot innovate, compete, or maintain its social model. By prioritizing health, the EU is essentially investing in the "human capital" necessary to fuel the green and digital transitions.
The Path Forward: A Call to Action for Member States
With the European Parliament having already shown its support, the bottleneck currently lies within the European Council. The coalition’s focus for the remainder of 2026 will be on lobbying individual Member States.
The challenge for the coalition is to convince finance ministers and heads of state that a dedicated health budget is not an encroachment on national sovereignty, but a collective investment that benefits all. They must bridge the gap between national health systems and EU-level policy, demonstrating that many of the health challenges facing Europeans—such as air pollution, climate-related health risks, and the spread of infectious diseases—are transnational by nature and require a unified, well-funded response.
As the negotiations intensify, the ERS and its partners have pledged to maintain the pressure. They have launched an extensive public-facing campaign to raise awareness about the link between the MFF and daily health outcomes, hoping to turn the budget negotiations into a matter of public interest.
The message remains firm: if the European Union is to fulfill its ambition of being a global leader in the 21st century, it must first ensure the health and well-being of its people. The current budget proposal is not just a line of numbers; it is a litmus test for the Union’s values and its long-term vision.
For those interested in the details of the appeal, the joint letter can be viewed here. Further information on the advocacy work being spearheaded by the ERS can be found on their official advocacy portal.
As the autumn negotiations approach, the world will be watching to see if the European Council chooses to treat health as a luxury, or as the essential foundation of a competitive and thriving future.
